Sofio

Glucose Monitoring (Diabetes Management)

Pre-clinical/DevelopmentActive

Key Facts

Indication
Glucose Monitoring (Diabetes Management)
Phase
Pre-clinical/Development
Status
Active
Company

About GlucoModicum

GlucoModicum is pioneering needle-free glucose monitoring through its novel magnetohydrodynamic (MHD) technology platform. Its first product, Sofio, is a modular, single-day wearable monitor designed to provide clear glucose insights without the need for needles or long-term sensor commitments. As a private, pre-revenue spinout, the company combines clinical research, engineering, and industrial development expertise to bring this disruptive solution to the large and growing diabetes market. Its success hinges on clinically validating and scaling its unique physics-based sensing approach.

View full company profile